Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,690 | -17,745 | -3,963 | -6,271 | -9,806 |
| Depreciation Amortization | 821 | 783 | 906 | 1,025 | 1,186 |
| Accounts receivable | -80 | N/A | N/A | 18 | N/A |
| Other Working Capital | 164 | -1,786 | 2,431 | -918 | 1,721 |
| Other Operating Activity | 2,307 | 1,106 | 3,455 | 115 | 54 |
| Operating Cash Flow | $-21,478 | $-17,642 | $2,829 | $-6,031 | $-6,845 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -91,657 | N/A | N/A | N/A | N/A |
| PPE Investments | -20 | -42 | -5 | 511 | 45 |
| Investing Cash Flow | $-91,677 | $-42 | $-5 | $511 | $45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,462 | 2,538 | N/A |
| Debt Repayment | N/A | N/A | -307 | -446 | -848 |
| Common Stock Issued | 75,593 | 57,990 | N/A | 141 | 2 |
| Other Financing Activity | 0 | 0 | 7,261 | 307 | 9,982 |
| Financing Cash Flow | $75,593 | $57,990 | $8,416 | $2,540 | $9,136 |
| Beginning Cash Position | 52,663 | 12,357 | 1,117 | 4,097 | 1,761 |
| End Cash Position | 15,101 | 52,663 | 12,357 | 1,117 | 4,097 |
| Net Cash Flow | $-37,562 | $40,306 | $11,240 | $-2,980 | $2,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,478 | -17,642 | 2,829 | -6,031 | -6,845 |
| Capital Expenditure | -20 | -42 | -5 | 0 | -15 |
| Free Cash Flow | -21,498 | -17,684 | 2,824 | -6,031 | -6,860 |